Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.

Deep-learning model takes a personalized approach to assessing each patient’s risk of lung cancer based on CT scans.

Biologists have mapped out more than 300 protein kinases and their targets, which they hope could yield new leads for cancer drugs.

Groundbreaking research can help alleviate the challenges affiliated with studying carbohydrates.

By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.

Researchers have developed a technique that could help fine-tune the production of monoclonal antibodies and other useful proteins.

Now in its second year, the Rise program targets exceptional teenage scholars from around the world for their potential as future change-makers.

Study finds the protein MTCH2 is responsible for shuttling various other proteins into the membrane of mitochondria. The finding could have implications for cancer treatments and MTCH2-linked conditions.

A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.

The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.